Oorja Bio

Oorja Bio is a private biotechnology company developing therapies for cardiopulmonary and fibrotic disorders. The company states that it aims to target the underlying pathophysiology of disease rather than only managing symptoms, with medicines intended to promote cellular repair and reverse or remodel fibrotic tissue. Publicly available descriptions position Oorja Bio as an early-stage, venture-backed company with operations in Houston and Boston. Its disclosed focus appears centered on fibrosis-related disease biology, especially in cardiopulmonary settings, but specific named drug candidates and molecular targets have not been broadly published.